Document is current

Any future updates will be listed below

Author response to: OSIN-D-24–00849 Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis

Crossref DOI link: https://doi.org/10.1007/s00198-024-07214-1

Published Online: 2024-08-09

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark